These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 15472188

  • 1. Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria.
    Favus MJ, Karnauskas AJ, Parks JH, Coe FL.
    J Clin Endocrinol Metab; 2004 Oct; 89(10):4937-43. PubMed ID: 15472188
    [Abstract] [Full Text] [Related]

  • 2. Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats.
    Karnauskas AJ, van Leeuwen JP, van den Bemd GJ, Kathpalia PP, DeLuca HF, Bushinsky DA, Favus MJ.
    J Bone Miner Res; 2005 Mar; 20(3):447-54. PubMed ID: 15746989
    [Abstract] [Full Text] [Related]

  • 3. Increased intestinal vitamin D receptor in genetic hypercalciuric rats. A cause of intestinal calcium hyperabsorption.
    Li XQ, Tembe V, Horwitz GM, Bushinsky DA, Favus MJ.
    J Clin Invest; 1993 Feb; 91(2):661-7. PubMed ID: 8381825
    [Abstract] [Full Text] [Related]

  • 4. Hypercalciuria: lessons from studies of genetic hypercalciuric rats.
    Favus MJ.
    J Am Soc Nephrol; 1994 Nov; 5(5 Suppl 1):S54-8. PubMed ID: 7873746
    [Abstract] [Full Text] [Related]

  • 5. Expression of vitamin D receptor, CYP27B1 and CYP24A1 hydroxylases and 1,25-dihydroxyvitamin D3 levels in stone formers.
    Melo TL, Esper PLG, Zambrano LI, Ormanji MS, Rodrigues FG, Heilberg IP.
    Urolithiasis; 2020 Feb; 48(1):19-26. PubMed ID: 31696245
    [Abstract] [Full Text] [Related]

  • 6. Elevated vitamin D receptor levels in genetic hypercalciuric stone-forming rats are associated with downregulation of Snail.
    Bai S, Wang H, Shen J, Zhou R, Bushinsky DA, Favus MJ.
    J Bone Miner Res; 2010 Apr; 25(4):830-40. PubMed ID: 19929616
    [Abstract] [Full Text] [Related]

  • 7. Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria.
    Ghazali A, Fuentès V, Desaint C, Bataille P, Westeel A, Brazier M, Prin L, Fournier A.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):32-8. PubMed ID: 8989228
    [Abstract] [Full Text] [Related]

  • 8. The relationship of 3' vitamin D receptor haplotypes to urinary supersaturation of calcium oxalate salts and to age at onset and familial prevalence of nephrolithiasis.
    Mossetti G, Rendina D, Viceconti R, Manno G, Guadagno V, Strazzullo P, Nunziata V.
    Nephrol Dial Transplant; 2004 Sep; 19(9):2259-65. PubMed ID: 15213319
    [Abstract] [Full Text] [Related]

  • 9. Expression of fibroblast growth factor 23, vitamin D receptor, and sclerostin in bone tissue from hypercalciuric stone formers.
    Menon VB, Moysés RM, Gomes SA, de Carvalho AB, Jorgetti V, Heilberg IP.
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1263-70. PubMed ID: 24763863
    [Abstract] [Full Text] [Related]

  • 10. 1,25(OH)₂D₃-enhanced hypercalciuria in genetic hypercalciuric stone-forming rats fed a low-calcium diet.
    Frick KK, Asplin JR, Krieger NS, Culbertson CD, Asplin DM, Bushinsky DA.
    Am J Physiol Renal Physiol; 2013 Oct 15; 305(8):F1132-8. PubMed ID: 23926184
    [Abstract] [Full Text] [Related]

  • 11. Association between intestinal vitamin D receptor, calcium absorption, and serum 1,25 dihydroxyvitamin D in normal young and elderly women.
    Kinyamu HK, Gallagher JC, Prahl JM, DeLuca HF, Petranick KM, Lanspa SJ.
    J Bone Miner Res; 1997 Jun 15; 12(6):922-8. PubMed ID: 9169351
    [Abstract] [Full Text] [Related]

  • 12. Regulation of renal calcium receptor gene expression by 1,25-dihydroxyvitamin D3 in genetic hypercalciuric stone-forming rats.
    Yao JJ, Bai S, Karnauskas AJ, Bushinsky DA, Favus MJ.
    J Am Soc Nephrol; 2005 May 15; 16(5):1300-8. PubMed ID: 15788476
    [Abstract] [Full Text] [Related]

  • 13. 1,25-Dihydroxyvitamin D3 up-regulates the renal vitamin D receptor through indirect gene activation and receptor stabilization.
    Healy KD, Frahm MA, DeLuca HF.
    Arch Biochem Biophys; 2005 Jan 15; 433(2):466-73. PubMed ID: 15581603
    [Abstract] [Full Text] [Related]

  • 14. Association between vitamin D receptor gene polymorphisms and fasting idiopathic hypercalciuria in recurrent stone-forming patients.
    Rendina D, Mossetti G, Viceconti R, Sorrentino M, Castaldo R, Manno G, Guadagno V, Strazzullo P, Nunziata V.
    Urology; 2004 Oct 15; 64(4):833-8. PubMed ID: 15491743
    [Abstract] [Full Text] [Related]

  • 15. Tissue specificity and mechanism of vitamin D receptor up-regulation during dietary phosphorus restriction in the rat.
    Sriussadaporn S, Wong MS, Pike JW, Favus MJ.
    J Bone Miner Res; 1995 Feb 15; 10(2):271-80. PubMed ID: 7754807
    [Abstract] [Full Text] [Related]

  • 16. Homologous up-regulation of vitamin D receptors is tissue specific in the rat.
    Gensure RC, Antrobus SD, Fox J, Okwueze M, Talton SY, Walters MR.
    J Bone Miner Res; 1998 Mar 15; 13(3):454-63. PubMed ID: 9525346
    [Abstract] [Full Text] [Related]

  • 17. Vitamin D status in urinary calcium stone formation.
    Netelenbos JC, Jongen MJ, van der Vijgh WJ, Lips P, van Ginkel FC.
    Arch Intern Med; 1985 Apr 15; 145(4):681-4. PubMed ID: 3872644
    [Abstract] [Full Text] [Related]

  • 18. Urinary citrate, bone resorption and intestinal alkali absorption in stone formers with fasting hypercalciuria.
    Messa P, Mioni G, Paganin L, Cruciatti A, Greco PL, Turrin D.
    Scanning Microsc; 1994 Apr 15; 8(3):531-8; discussion 538-9. PubMed ID: 7747155
    [Abstract] [Full Text] [Related]

  • 19. Familial calcium stone disease: TaqI polymorphism and the vitamin D receptor.
    Jackman SV, Kibel AS, Ovuworie CA, Moore RG, Kavoussi LR, Jarrett TW.
    J Endourol; 1999 May 15; 13(4):313-6. PubMed ID: 10405913
    [Abstract] [Full Text] [Related]

  • 20. Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria.
    Pacifici R, Rothstein M, Rifas L, Lau KH, Baylink DJ, Avioli LV, Hruska K.
    J Clin Endocrinol Metab; 1990 Jul 15; 71(1):138-45. PubMed ID: 2370292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.